Cambrian BioPharma Inc
SEC Form 4 insider trading activity
Cambrian BioPharma Inc has filed 3 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 1, 2026.
On the most recent filing, Cambrian BioPharma Inc is listed as 10% Owner at Sensei Biotherapeutics, Inc. Inside the rolling window, Cambrian BioPharma Inc reported no open-market purchases and 4 open-market sales totaling $788K in SNSE. The largest disclosed transaction in the window is a sale of 25,000 SNSE shares on Jun 1, 2026, worth $501K.
Companies traded
Other insiders at SNSE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$788K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cambrian BioPharma Inc made?
Cambrian BioPharma Inc has filed 3 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Cambrian BioPharma Inc trade?
Cambrian BioPharma Inc has filed SEC Form 4 disclosures for 1 company, including SNSE.
When was Cambrian BioPharma Inc's most recent SEC Form 4 filing?
Cambrian BioPharma Inc's most recent SEC Form 4 filing on Tracefour is dated Jun 1, 2026.
What is Cambrian BioPharma Inc's total buy and sell value in the current window?
Inside the rolling retention window, Cambrian BioPharma Inc bought $0 and sold $788K based on SEC Form 4 filings.
What was Cambrian BioPharma Inc's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 SNSE shares on 2026-06-01, worth $501K, per SEC Form 4 filings.